Objectively measured physical activity and its influence on physical capacity and clinical parameters in patients with primary Sjögren's syndrome.

Abstract:

:Objective The objectives of this paper are to objectively measure habitual physical activity levels in patients with primary Sjögren's syndrome (pSS) with mild disease activity and to determine to which extent it may be associated with physical capacity and function and clinical features. Methods In this cross-sectional study, 29 women with pSS were objectively assessed for habitual physical activity levels (using accelerometry) and compared with 20 healthy women (CTRL) frequency-matched for physical activity levels, age, body mass index, and body fat percentage with regard to physical capacity and function, fatigue, depression, pain, and health-related quality of life. Results pSS showed 8.5 min/day of moderate-to-vigorous physical activity (MVPA) when only MVPA accumulated in bouts ≥ 10 min was considered; when considering total MVPA (including bouts < 10 min), average levels were 26.3 min/day, with 62% of pSS patients achieving the recommendation (≥ 21.4 min/day). Moreover, pSS showed lower VO2peak, lower muscle strength and function, higher fatigue, and poorer health-related quality of life when compared with CTRL ( p < 0.05). These differences (except for aerobic capacity) were sustained even when only individuals achieving the minimum of 21.4 min/day of total MVPA in both groups were compared. Finally, MVPA time was significantly correlated with aerobic conditioning, whereas total counts and sedentary time were associated with lower-body muscle strength and the bodily-pain domain of SF-36 in patients with pSS. Conclusion When compared to physical activity-matched healthy controls, pSS patients showed reduced physical capacity and function, increased fatigue and pain, and reduced health-related quality of life. Except for aerobic conditioning, these differences were sustained when only more physically active participants were compared, indicating that minimum recommended levels of physical activity for the general population may not be sufficient to counteract pSS comorbidities.

journal_name

Lupus

journal_title

Lupus

authors

Dassouki T,Benatti FB,Pinto AJ,Roschel H,Lima FR,Augusto K,Pasoto S,Pereira RMR,Gualano B,de Sá Pinto AL

doi

10.1177/0961203316674819

subject

Has Abstract

pub_date

2017-06-01 00:00:00

pages

690-697

issue

7

eissn

0961-2033

issn

1477-0962

pii

0961203316674819

journal_volume

26

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Evaluation of polymorphic variants in apoptotic genes and their role in susceptibility and clinical progression to systemic lupus erythematosus.

    abstract::Background Systemic lupus erythematosus (SLE) is an autoimmune disease marked by the disruption of the immune homeostasis. Patients exhibit a wide range of clinical manifestations, and environmental and genetic factors are involved in SLE pathogenesis. Evidence suggests that abnormalities in the cellular and molecular...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316678671

    authors: Glesse N,Vianna P,Paim LMG,Matte MCC,Aguiar AKK,Palhano PL,Monticielo OA,Brenol CV,Xavier RM,Chies JAB

    更新日期:2017-06-01 00:00:00

  • Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand.

    abstract::Background The prevalence and variation by ethnicity of cutaneous lupus in New Zealand is not known. Therefore, a cross-sectional study to determine the prevalence and variation by ethnicity of cutaneous lupus in the ethnically diverse community of South Auckland, New Zealand, was undertaken. Methods Multiple sources ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316651745

    authors: Jarrett P,Thornley S,Scragg R

    更新日期:2016-11-01 00:00:00

  • Pathological manifestation of autoimmune myocarditis is detected prior to glomerulonephritis in a murine model of lupus nephritis.

    abstract:OBJECTIVE:Since enhanced cardiac magnetic resonance imaging (cMRI) signals have been associated with lupus disease activity in humans prior to renal failure and novel, cardiac-focused therapeutic strategies could be investigated with an associated animal model, autoimmune myocarditis was characterized in murine lupus n...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320948959

    authors: Young NA,Jablonski K,Schwarz E,Okafor I,Hampton J,Valiente GR,Henry C,Harb P,Barger J,Bratasz A,Kalyanasundaram A,Ardoin SP,Jarjour WN

    更新日期:2020-11-01 00:00:00

  • Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach.

    abstract::Systemic lupus erythematosus (SLE) is a multi-organ inflammatory disorder mainly affecting women and is associated with high cardiovascular morbidity and mortality. We tested the utility of a comprehensive cardiovascular magnetic resonance approach to assess myocardial involvement and to determine its relation to dise...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089401

    authors: Abdel-Aty H,Siegle N,Natusch A,Gromnica-Ihle E,Wassmuth R,Dietz R,Schulz-Menger J

    更新日期:2008-06-01 00:00:00

  • Cytomegalovirus infection in Systemic Lupus Erythematosus: report of four cases challenging the management of the disease, and literature review.

    abstract::Cytomegalovirus (CMV) is particularly dangerous in systemic lupus erythematosus (SLE), being a problem both for the differential diagnosis with disease flare and for the management of SLE flare with immunosuppressive drugs. We report on four cases of SLE with concomitant CMV infection, having some common clinical and ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319825570

    authors: Sebastiani GD,Iuliano A,Canofari C,Bracci M

    更新日期:2019-03-01 00:00:00

  • Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry).

    abstract:BACKGROUND:Systemic lupus erythematosus (SLE) is regarded as a prototype autoimmune disease because it can serve as a means for studying differences between ethnic minorities and sex. Traditionally, all Hispanics have been bracketed within the same ethnic group, but there are differences between Hispanics from Spain an...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203319889667

    authors: Hernández Cruz B,Alonso F,Calvo Alén J,Pego-Reigosa JM,López-Longo FJ,Galindo-Izquierdo M,Olivé A,Tomero E,Horcada L,Uriarte E,Erausquin C,Sánchez-Atrio A,Montilla C,Santos Soler G,Fernández-Nebro A,Blanco R,Rodríguez-Góm

    更新日期:2020-01-01 00:00:00

  • Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a clinically diverse, complex autoimmune disease which may present with coincident onset of many criteria or slow, gradual symptom accrual. Early intervention has been postulated to delay or prevent the development of more serious sequelae. One option for treatment in this setting...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307078579

    authors: James JA,Kim-Howard XR,Bruner BF,Jonsson MK,McClain MT,Arbuckle MR,Walker C,Dennis GJ,Merrill JT,Harley JB

    更新日期:2007-01-01 00:00:00

  • Allogeneic adipose-derived stem cells suppress mTORC1 pathway in a murine model of systemic lupus erythematosus.

    abstract:OBJECTIVE:The aim of our study was to investigate the efficacy of adipose-derived stem cells (ADSC) transplantation in systemic lupus erythematosus (SLE) and to determine the mechanism of ADSC transplantation. METHODS:B6.MRL/lpr mice were administered ADSC intravenously every week from age 28 to 31 weeks, while the lu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318819131

    authors: Wei S,Xie S,Yang Z,Peng X,Gong L,Zhao K,Zeng K,Lai K

    更新日期:2019-02-01 00:00:00

  • Complementemia in pregnancies with antiphospholipid syndrome.

    abstract::Prognosis of pregnancies in women with antiphospholipid syndrome has dramatically improved over the past two decades using conventional treatment with low molecular weight heparin and low-dose aspirin. However, despite this regimen, 10-15% of antiphospholipid syndrome patients experience pregnancy losses. Several stud...

    journal_title:Lupus

    pub_type: 社论

    doi:10.1177/0961203319882507

    authors: Tabacco S,Giannini A,Garufi C,Botta A,Salvi S,Del Sordo G,Benedetti Panici P,Lanzone A,De Carolis S

    更新日期:2019-11-01 00:00:00

  • Early-stage predictors for treatment responses in patients with active lupus nephritis.

    abstract:OBJECTIVE:We analyzed data of lupus nephritis (LN) patients to find parameters that can predict remission. METHODS:Sixty-four LN patients who were diagnosed with class III, IV, V or V + III/IV by renal biopsy and were followed up for more than six months in our center were enrolled retrospectively. Receiver operating ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319826703

    authors: Liu G,Wang H,Le J,Lan L,Xu Y,Yang Y,Chen J,Han F

    更新日期:2019-03-01 00:00:00

  • Neurodevelopmental disorders in children born to mothers with systemic lupus erythematosus.

    abstract::Children born to women with systemic lupus erythematosus seem to have a potentially increased risk of neurodevelopmental disorders compared to children born to healthy women. Recent experimental data suggest in utero exposure to maternal antibodies and cytokines as important risk factors for neurodevelopmental disorde...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314541691

    authors: Vinet É,Pineau CA,Clarke AE,Fombonne É,Platt RW,Bernatsky S

    更新日期:2014-10-01 00:00:00

  • Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus.

    abstract::Peripheral T cell apoptosis is upregulated in active SLE, in parallel with high expression of both membrane-bound and soluble (s) Fas. Previous studies postulated that sFas down-regulates apoptosis in vitro through its blockade of the Fas-L of cytotoxic cells. We have investigated the extent of apoptosis and sFas leve...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu250oa

    authors: Silvestris F,Grinello D,Tucci M,Cafforio P,Dammacco F

    更新日期:2003-01-01 00:00:00

  • Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study.

    abstract:OBJECTIVE:The objective of this paper is to assess whether pulmonary hypertension (PH) may be detected at one point in time or longitudinally predicted by serum uric acid (sUA) levels in systemic lupus erythematosus (SLE). METHODS:We conducted a post-hoc analysis of a long-term followed cohort of Mexican SLE patients....

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315600539

    authors: Castillo-Martínez D,Marroquín-Fabián E,Lozada-Navarro AC,Mora-Ramírez M,Juárez M,Sánchez-Muñoz F,Vargas-Barrón J,Sandoval J,Amezcua-Guerra LM

    更新日期:2016-01-01 00:00:00

  • Drug-induced subacute cutaneous lupus erythematosus associated with abatacept.

    abstract::Numerous drugs have been linked to the induction or exacerbation of systemic cutaneous lupus erythematosus (SCLE). This report presents the third case of the biologic abatacept as an exacerbating medication for SCLE. A 73-year old woman with a remote history of subacute cutaneous lupus and rheumatoid arthritis, well c...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320981146

    authors: Figueredo Zamora E,Callen JP,Schadt CR

    更新日期:2020-12-22 00:00:00

  • The effect of acute physical exercise on cytokine levels in patients with systemic lupus erythematosus.

    abstract:BACKGROUND:Acute exercise increases IL-6, IL-10 and TNF-α levels in healthy subjects. There is no study evaluating the effect of exercise on cytokines level in systemic lupus erythematosus (SLE) patients. OBJECTIVE:Our aim was to assess IL-10, IL-6 and TNF-α levels at baseline and after acute physical exercise in pati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313508832

    authors: da Silva AE,dos Reis-Neto ET,da Silva NP,Sato EI

    更新日期:2013-12-01 00:00:00

  • Systemic lupus erythematosus pregnancies: a case series from a tertiary, East Malaysian hospital.

    abstract::We performed a retrospective study of all systemic lupus erythematosus (SLE) pregnancies during a two-year period (2006-2007) to describe the clinical features, maternal and foetal outcomes in our centre. There were 17 pregnancies in 16 women with SLE. Our patients have a mean age of 28.31 years (SD 5.24) and a mean d...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308096661

    authors: Teh CL,Wong JS,Ngeh NK,Loh WL

    更新日期:2009-03-01 00:00:00

  • Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation.

    abstract:OBJECTIVE:Arthritis is frequently seen in human lupus, but rarely in lupus models. Pristane-induced lupus (PIL) can be induced in various mouse strains such as BALB/c and C57BL/6. We herein characterize clinical and histological features of arthritis in the context of systemic lupus and provide a prudent comparison wit...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313492869

    authors: Leiss H,Niederreiter B,Bandur T,Schwarzecker B,Blüml S,Steiner G,Ulrich W,Smolen JS,Stummvoll GH

    更新日期:2013-07-01 00:00:00

  • From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link?

    abstract::The heart lesions of rheumatic fever and the heart involvement in antiphospholipid syndrome (APS), have different clinical pictures. Yet, there are several common characteristics linking both diseases: 1) central nervous system (CNS) and heart involvement; 2) molecular mimicry between the a pathogen and the origin of ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2203oa

    authors: Blank M,Aron-Maor A,Shoenfeld Y

    更新日期:2005-01-01 00:00:00

  • Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study.

    abstract::Cyclophosphamide (CYC) is used in severe neuropsychiatric systemic lupus erythematosus (NPSLE), but long-term data regarding its efficacy and safety are lacking. We identified NPSLE cases who received CYC from two centres during the period 1999-2013 and had regular follow-up. General and neuropsychiatric outcome at la...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203315622821

    authors: Fanouriakis A,Pamfil C,Sidiropoulos P,Damian L,Flestea A,Gusetu G,Rednic S,Bertsias G,Boumpas DT

    更新日期:2016-05-01 00:00:00

  • Familial SLE: sustained drug-free remission in a mother successfully treated for anal cancer, but development of SLE in a 16-year old daughter.

    abstract::The immunopathogenesis of systemic lupus erythematosus has been thoroughly investigated recently, and genome-wide association studies have identified genes statistically associated with lupus. However, the progression to overt disease is dependent on the activation of environmental factors ('triggers'), among which oe...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311433138

    authors: Catania G,Rossi E,Marmont A

    更新日期:2012-05-01 00:00:00

  • Maternal and fetal outcomes of lupus pregnancies: A collective effort by Karnataka Rheumatologists.

    abstract:INTRODUCTION:Identifying factors predicting adverse pregnancy outcomes involving systemic lupus erythematosus (SLE) is a research priority. The aims of this study were to investigate (a) the maternal and fetal outcomes of pregnant lupus patients and the factors associated with adverse pregnancy outcomes, and (b) the ef...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320944503

    authors: Janardana R,Haridas V,Priya V,Bhat V,Singh Y,Rao VK,Jois R,Srikantiah C,Pinto B,Shobha V

    更新日期:2020-10-01 00:00:00

  • Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study.

    abstract::Controversy exists concerning the prevalence of headache in systemic lupus erythematosus (SLE) and its importance as a neuropsychiatric manifestation, especially when it occurs independently of disease activity and with the typical characteristics of primary chronic headache. Most reports to date have either studied b...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847443

    authors: Fernández-Nebro A,Palacios-Muñoz R,Gordillo J,Abarca-Costalago M,De Haro-Liger M,Rodríguez-Andreu J,González-Santos P

    更新日期:1999-01-01 00:00:00

  • Urinary biomarkers for lupus nephritis: the role of the vascular cell adhesion molecule-1.

    abstract::Renal involvement is one of the main complications of systemic lupus erythematosus, causing a significant impact on patients' morbidity and mortality. Renal biopsy is still the gold standard of diagnosis, but it has many limitations. In this sense, several recent studies aim to identify biomarkers that not only predic...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203319826695

    authors: Gasparin AA,Pamplona Bueno de Andrade N,Hax V,Tres GL,Veronese FV,Monticielo OA

    更新日期:2019-03-01 00:00:00

  • Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity?

    abstract::Neonatal antiphospholipid syndrome (neonatal APS) seems to be exceedingly rare, as the antiphospholipid antibodies (aPL) related thrombosis in the neonatal period. The pathogenesis of perinatal aPL related thrombosis may be explained both by the transplacental passage of the maternal antibodies and by the production o...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314560207

    authors: De Carolis MP,Salvi S,Botta A,Cocca C,Garufi C,Lanzone A,De Carolis S

    更新日期:2015-03-01 00:00:00

  • Vitamin D and cutaneous lupus erythematosus: effect of vitamin D replacement on disease severity.

    abstract:BACKGROUND:The main vitamin D source is exposure to ultraviolet radiation, which aggravates cutaneous lupus erythematosus (CLE). OBJECTIVES:The aims of this study were to identify variables associated with lower serum 25-hydroxyvitamin D [25(OH)D] levels in CLE patients and assess the effect of vitamin D restoration o...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314522338

    authors: Cutillas-Marco E,Marquina-Vila A,Grant WB,Vilata-Corell JJ,Morales-Suárez-Varela MM

    更新日期:2014-06-01 00:00:00

  • Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement.

    abstract::Objective Several studies have evaluated the prevalence of rheumatoid factor (RF) and anti-citrullinated proteins antibodies (ACPA) in systemic lupus erythematosus (SLE) patients but no data are available on the anti-carbamylated proteins (anti-CarP), a new biomarker for rheumatoid arthritis (RA). We evaluated the ant...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317713141

    authors: Massaro L,Ceccarelli F,Colasanti T,Pendolino M,Perricone C,Cipriano E,Natalucci F,Capalbo G,Lucchetti R,Pecani A,Vomero M,Mancini R,Spinelli FR,Alessandri C,Valesini G,Conti F

    更新日期:2018-01-01 00:00:00

  • High-dose cyclophosphamide for severe systemic lupus erythematosus.

    abstract::Cytotoxic therapy is a cornerstone for patients with severe systemic lupus erythematosus (SLE). High-dose cyclophosphamide, 200 mg/kg, can induce a complete remission without the need for stem cell rescue in patients with autoimmune illnesses. Here we report on our first four patients treated for severe SLE with this ...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1191/0961203302lu229oa

    authors: Gladstone DE,Prestrud AA,Pradhan A,Styler MJ,Topolsky DL,Crilley PA,Hoch S,Huppert A,Brodsky I

    更新日期:2002-01-01 00:00:00

  • Association of ficolin-2 gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multicenter study.

    abstract:BACKGROUND:Pediatric-onset SLE (pSLE) is a multisystem autoimmune disease. Recently, the ficolin-2 (FCN2) gene has emerged as a potential candidate gene for susceptibility to SLE. OBJECTIVES:The objective of this study was to evaluate the association of the FCN2 gene polymorphisms at positions -986 (G/A), -602 (G/A), ...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203319856089

    authors: Elkoumi MA,Emam AA,Allah MAN,Sherif AH,Abdelaal NM,Mosabah A,Zakaria MT,Soliman MM,Salah A,Sedky YM,Mashali MH,Elashkar SSA,Hafez SFM,Hashem MIA,Elshreif AM,Youssef M,Fahmy DS,Sallam MM,Nawara AM,Elgohary EA,Ahmed

    更新日期:2019-07-01 00:00:00

  • Monoclonal gammopathy in systemic lupus erythematosus.

    abstract::In order to ascertain the incidence of monoclonal gammopathy (MG) in systemic lupus erythematosus (SLE), 120 SLE patients were evaluated. Four patients (3.3%), two of whom were under 50 years of age, were found to have a monoclonal immunoglobulin in their serum. Our data agree with the previous literature in demonstra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100410

    authors: Porcel JM,Ordi J,Tolosa C,Selva A,Castro-Salomo A,Vilardell M

    更新日期:1992-08-01 00:00:00

  • Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.

    abstract::Objectives Avascular necrosis (AVN) is one of the most common causes of organ damage in patients with systemic lupus erythematosus (SLE) and often causes serious physical disability. The aims of this study were to investigate clinical risk factors associated with symptomatic AVN and to analyze their synergistic effect...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318784648

    authors: Kwon HH,Bang SY,Won S,Park Y,Yi JH,Joo YB,Lee HS,Bae SC

    更新日期:2018-09-01 00:00:00